Pediatric Primary Immunodeficiency Disease (PID) in China
Clinical Characteristics and Prognosis of Primary Immunodeficiency Disease (PID) in Chinese Children
Sponsor: Beijing Children's Hospital
Listed as NCT03252548, this observational or N/A phase trial focuses on Primary Immunodeficiency Disease and remains ongoing. Sponsored by Beijing Children's Hospital, it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Not Yet Recruiting
-
Jun 2018 — Jan 2021 [monthly]
Not Yet Recruiting
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing Children's Hospital
- Capital Institute of Pediatrics, China
- Shenzhen Children's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.